Glaucoma: systemic side effects of topical medical therapy—a common and under recognized problem

P Diggory, W Franks - Journal of the Royal Society of …, 1994 - journals.sagepub.com
Chronic open angle glaucoma is asymptomatic and generally detected by optometrists. It is
increasingly common with age affecting about 5% of those over 65 and is responsible for …

Medical treatment of glaucoma--a reappraisal of the risks.

P Diggory, W Franks - The British journal of ophthalmology, 1996 - ncbi.nlm.nih.gov
There has been an accumulation of evidence in recent years to demonstrate that surgical
treatment is more effective than eyedrops at lowering intraocular pressure and preserving …

Compliance with treatment of patients with chronic open-angle glaucoma.

JM MacKean, AR Elkington - The British Journal of Ophthalmology, 1983 - ncbi.nlm.nih.gov
The compliance with treatment of 168 patients with chronic open-angle glaucoma was
studied. 42% of the patients missed at least some of their medication. Patients were more …

Beta blockers and the elderly with glaucoma: are we adding insult to injury?

E O'Donoghue - The British Journal of Ophthalmology, 1995 - ncbi.nlm.nih.gov
Many elderly people tend not to complain in the face of often serious disease but stoically
accept'every tatter in their mortal dress'l as the inevitable price of aging. We, their carers …

General medicine and visual side effects.

S Davidson - British Medical Journal, 1979 - ncbi.nlm.nih.gov
The drug of choice for pupillary dilatation for ophthalmoscopy is tropicamide (Mydriacyl) 0 5,
o, on account of its rapid onset, producing a mydriasis of short duration with minimal effect …

Outcome measures for glaucoma treatment

RA Hitchings - British journal of ophthalmology, 1997 - bjo.bmj.com
Care for the glaucomas should be directed towards removing the causative factor. Rarely
(for example, steroid induced glaucoma) is this possible. More usually no treatable factor is …

Glaucoma: diagnosis and management

DA Infeld, JG O'Shea - Postgraduate medical journal, 1998 - academic.oup.com
Glaucoma is the third most prevalent cause of global blindness, accounting for over 5 million
blind. It is common in Western Countries; the estimated prevalence of primary open angle …

[PDF][PDF] Topical ophthalmic medications: what potential for systemic side effects and interactions with other medications?

I Goldberg, G Moloney, P McCluskey - Medical Journal of Australia, 2008 - mja.com.au
[Pfizer]), all of which contain the β-blocker timolol;(iii) ophthalmologists (and now
optometrists) should be aware of a patient's concurrent systemic health and medication …

Sublingual timolol--an alternative to topical medication in glaucoma?

SA Sadiq, SA Vernon - British journal of ophthalmology, 1996 - bjo.bmj.com
AIMS--To assess whether timolol drops lower a raised intraocular pressure (IOP) when
given sublingually. This route of administration would be useful for glaucoma patients who …

The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care

DN Bateman, R Clark, A Azuara-Blanco… - British journal of …, 2002 - bjo.bmj.com
Background: The management of glaucoma has been changed in the past decade by the
introduction of new drugs. The impact of these changes on clinical care of patients was …